Filters

Anti-Human CXCR1

Anti-Human CXCR1 size: 100ug 336

Price 336
Size 100ug
Gene NameCXCR1
Species ReactivityHuman (Homo sapiens)
Synonyms CKR-1 CDw128a CD181
UniprotP25024
Description this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, Properly used, This is a highly purified antibody with strong binding affinity towards the antigen that it has been risen against
Storage and handling Generally, Reconstituted lyophilised and antibodies in liquid form can be shipped and stored for short terms at +4 degrees Celsius, it is recomended for long term storage (up to one year) 25-50% glycerol or ethylene glycol to be added and the vial must be stored at -20°, C, Lyophilized antibodies can be shipped at ambient temperature and stored for short terms at +4 degrees Celsius and at -20 for long term storage
Advisory For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of the antibodies unchanged
Properties Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine,  , (Homo sapiens, Homo sapiens sapiens), Human proteins, humans , ssp
Gene targetCXCR1
Short nameAnti- CXCR1
Species Humans, Human
Alternative name sapiens chemokine (C-X-C motif) receptor 1, antibody to-H
Alternative to gene target C-C and C-C-CKR-1 and CD128 and CD181 and CDw128a and CKR-1 and CMKAR1 and IL8R1 and IL8RA and IL8RBA, CXCR1 and IDBG-80821 and ENSG00000163464 and 3577, Cxcr1 and IDBG-166431 and ENSMUSG00000048480 and 227288, Plasma membranes, interleukin-8 binding, this GO :0002407 and dendritic cell chemotaxis and biological process this GO :0004918 and interleukin-8 receptor activity and molecular function this GO :0004930 and G-protein coupled receptor activity and molecular function this GO :0004950 and chemokine receptor activity and molecular function this GO :0005886 and plasma membrane and cellular component this GO :0006935 and chemotaxis and biological process this GO :0006954 and inflammatory response and biological process this GO :0007166 and cell surface receptor signaling pathway and biological process this GO :0007186 and G-protein coupled receptor signaling pathway and biological process this GO :0016020 and membrane and cellular component this GO :0016021 and integral component of membrane and cellular component this GO :0019959 and interleukin-8 binding and molecular function this GO :0031623 and receptor internalization and biological process this GO :0038112 and interleukin-8-mediated signaling pathway and biological process this GO :0070098 and chemokine-mediated signaling pathway and biological process, this GO :0004918: interleukin-8 receptor activity, this GO :0004918: interleukin-8 receptor activity and also this GO :0004930: G-protein coupled receptor activity and also this GO :0004950: chemokine receptor activity and also this GO :0019959: interleukin-8 binding, this GO :0004930: G-protein coupled receptor activity, this GO :0004950: chemokine receptor activity, this GO :0019959: interleukin-8 binding, chemokine (C-X-C motif) receptor 1
Identity 6026
Gene CXCR1
Long gene name C-X-C motif chemokine receptor 1
Synonyms gene CMKAR1 IL8RA
Synonyms gene name alpha chemokine (C-X-C motif) receptor 1 , interleukin 8 receptor
Locus 2q35
Discovery year 1992-11-09
GenBank acession U11870
Entrez gene record 3577
Pubmed identfication 1303245 1427896
RefSeq identity NM_000634
Classification CD molecules C-X-C motif chemokine receptors Interleukin receptors
Havana BLAST/BLAT OTTHUMG00000133108

Subscribe to our Newsletter